NCT06552832 CAVEAT: An Open-Trial Feasibility Study
| NCT ID | NCT06552832 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Lausanne Hospitals |
| Condition | Parent-Child Relations |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-07-01 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an open-clinical trial to study the feasibility of a brief manualized psychotherapy for mothers interpersonal violence-related posttraumatic stress disorder (PTSD) and their very young children ages 1-3 years, entitled: Clinician-Assisted Videofeedback Exposure Approach Therapy (CAVEAT). This project, to be conducted with referred mothers and children to an academic medical center ambulatory care setting, intends to pilot along with the manualized intervention, pre- and post-intervention measures for up to 10 dyads over 2 years.
Eligibility Criteria
Inclusion Criteria: * French-speaking, biological child living with mother Exclusion Criteria: * Physical and/or mental handicap that can interfere with participation in play and measures, active psychotic illness or substance abuse
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06552832 clinical trial?
This trial is open to participants of all sexes, aged 12 Months or older, up to 50 Years, studying Parent-Child Relations. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06552832 currently recruiting?
Yes, NCT06552832 is actively recruiting participants. Contact the research team at daniel.schechter@chuv.ch for enrollment information.
Where is the NCT06552832 trial being conducted?
This trial is being conducted at Lausanne, Switzerland.
Who is sponsoring the NCT06552832 clinical trial?
NCT06552832 is sponsored by University of Lausanne Hospitals. The trial plans to enroll 20 participants.